Fujifilm Diosynth Biotechnologies has agreed to dedicate space at its plant in Hillerod, Denmark to the COVID-19 Therapeutics Accelerator. Fujifilm Diosynth Biotechnologies (FDB) will work with a pharmaceutical partner to support the swift manufacture of a COVID-19 therapy for patients in lower-income countries. According to the contract development and manufacturing organization (CDMO) the deal includes drug substance manufacture along with supporting drug product (DP) and assembly, label and packaging of COVID-19 therapeutics. CEO Martin Meeson told us “Under the agreement,…